Market Newsdesk

New release makes it easier than ever to securely share sensitive files across more systems

BEDFORD, Mass., May 11, 2021 (GLOBE NEWSWIRE) — Progress (NASDAQ: PRGS), the leading provider of products to develop, deploy, and manage high-impact business applications, today announced the release of Progress® MOVEit® 2021, the secure, automated Managed File Transfer (MFT) software that can be deployed both on-premises and in the cloud. With enhancements such as data encryption key rotation, MOVEit Transfer notification branding, REST API improvements and more, MOVEit 2021 managed file transfer directly addresses the most critical market developments and top customer concerns in security, usability and integration.

“In 2020 over 40% of the global population turned to remote work models. With the ebb and flow of the global pandemic in 2021, hybrid work models are enabling some people to return to on-site work while others continue to work remotely or move between remote and on-site work,” said Stewart Bond, research director, Data Integration and Intelligence software research at IDC. “Businesses must adjust their strategies to manage this new hybrid workforce and maintain secure and trusted remote file transfers to safeguard the sharing of data.”

Today’s file transfer environment demands the ability to quickly and easily share critical information without risking the security of this information. A secure and reliable data transfer platform ensures visibility across core business processes and provides compliant transfer of sensitive data between partners, customers, users and systems.

Progress MOVEit 2021 makes it easy for users to safely transfer data and collaborate with each other—all while improving business scalability and minimizing IT burden. New security enhancements in MOVEit 2021 include:

• Data Encryption Key Rotation – MOVEit 2021 enables security administrators to automatically rotate data encryption keys, as well as schedule, pause, restart and report upon data encryption key status.

• IP/Username Lockout Mechanism — MOVEit Automation administrators can now set automatic lockouts for users or IP addresses that fail login attempts too many times, providing an additional layer of security often required by larger organizations and enterprises.

• Multi-factor Authentication (MFA) Support for the Desktop MOVEit Client – New MFA support for the MOVEit desktop client means better security at every access point of an organization’s network. 

MOVEit 2021 also gives customers new features for easier implementation and enhanced integrations, including:

• S3 Compatible Host Support – MOVEit Automation administrators can now create hosts for third-party storage solutions that use Amazon’s S3 protocol. This expands the variety of storage locations available for hybrid cloud workflows. 

• HTML Email Notifications – MOVEit Automation automatically generated emails can now be formatted in HTML as well as plain text. This includes support for links, fonts, bullets, tables, macros and more. These changes make it easier for users to customize and validate email notifications.

• Branded Emails – Email notifications generated by MOVEit Transfer can now include the branding or logo associated with a user interface, helping recipients recognize email notifications as being trustworthy.

• Updated User Interface for Advanced Task Configuration – UI improvements to the Advanced Task Configuration Interface make the web-based tool easier to use and improve productivity when creating workflows—all without needing to download and install a client application.

• REST API Enhancements – A wide variety of REST API enhancements have been added to MOVEit, giving users far more options for integrating with third party systems and automating workflows.

“As the economy becomes increasingly digital, the growing cyber threat is outpacing most companies’ ability to manage it effectively,” said John Ainsworth, SVP, Core Products, Progress. “With more than half of the new security, usability, and integration enhancements in MOVEit 2021 developed in response to changing market dynamics, we are committed to helping our customers keep their critical information safe.”

Progress MOVEit 2021 is available today. For more information, click here or attend the MOVEit 2021 release webinar on May 25 at 2:00 p.m. ET. Register for the event here.

Additional Resources

• Follow Progress on Twitter, Facebook and LinkedIn
• Read the Progress blog

About Progress

Progress (NASDAQ: PRGS) provides the best products to develop, deploy and manage high-impact business applications. Our comprehensive product stack is designed to make technology teams more productive, and we have a deep commitment to the developer community, both open source and commercial alike. With Progress, organizations can accelerate the creation and delivery of strategic business applications, automate the process by which apps are configured, deployed and scaled, and make critical data and content more accessible and secure – leading to competitive differentiation and business success. Over 1,700 independent software vendors, 100,000+ enterprise customers, and a three-million-strong developer community rely on Progress to power their applications. Learn about Progress at www.progress.com or +1-800-477-6473.

Progress and MOVEit are trademarks or registered trademarks of Progress Software Corporation and/or one of its subsidiaries or affiliates in the US and other countries. Any other trademarks contained herein are the property of their respective owners.

Press Contacts:

Kim Baker
Progress
+1 781-280-4000
[email protected]

PORTLAND, ORE., May 11, 2021 (GLOBE NEWSWIRE) — The uKeg TWIST Hard Seltzer Maker crowdfunding campaign proves demand for hard seltzer—and appreciation for craft beverage innovation—are as strong as ever.

After hitting its funding goal in the first six hours, the uKeg TWIST from GrowlerWerks went on to raise $279,344 from nearly 3,000 backers on Kickstarter during a 5-week campaign.

Setting itself apart from other players in the hard seltzer space, the uKeg TWIST lets people prepare their own customized seltzer on-the-fly, then take it with them in the same vessel for easy drinking and dispensing. After adding water and any favorite ingredients to the TWIST, all it takes is an 8-gram CO2 cartridge and a quick shake to make fresh seltzer that’s perfectly tailored to one’s individual preferences. The TWIST comes in 24 oz and 36 oz sizes and keeps seltzer cold and fizzy all day long.

Judging from the response it’s received so far, the uKeg TWIST is poised to change the way people enjoy hard seltzer.

“The hard seltzer market has been so hot that we were confident the uKeg TWIST would hit its funding goal, but we were really excited to see it take off the way it did,” said GrowlerWerks founder and president, Shawn Huff. “I’ve also loved seeing how many of our current customers jumped onboard to back the TWIST. It’s a real testament to the energy and enthusiasm of the craft beverage community that’s been supporting us since we released the uKeg carbonated growler in 2014.”

Building on the success of the Kickstarter campaign, the uKeg TWIST is now available for pre-order on Indiegogo Indemand. Available perks come with two CO2 cartridges and discounts up to 47% off. They also include a sample pack of 5 all-natural flavor drops that make creating delicious seltzer even easier. Just add the drops along with water and vodka (or another liquor of your choice) and you’ll have fresh, flavorful hard seltzer in less than a minute.

The uKeg TWIST is expected in retail this fall, with an MSRP of $64.95 or $79.95, depending on the size.

About GrowlerWerks®

Founded in Portland, Ore. in 2014, GrowlerWerks is an innovator in the craft beverage industry. The uKeg pressurized growler changed the way craft beer is enjoyed by allowing beer enthusiasts to keep their favorite beverage fresh and carbonated for weeks. The uKeg Nitro is the first at-home nitro cold brew coffee maker and dispenser. GrowlerWerks’ products are distributed in the US, Canada, Australia and Western Europe. 

Attachment

• TWIST 11.jpg

SAN JOSE, Calif., May 11, 2021 (GLOBE NEWSWIRE) — NeuVector, the leader in Full Lifecycle Container Security, today announced two leadership team additions to support customer and partner growth. Joining NeuVector are Zach Hill as Vice President of Sales and Susan Don as Vice President of Business Development.

“These key hires round out NeuVector’s leadership team and position us for accelerated growth,” said Stephanie Fohn, CEO, NeuVector. “As enterprise adoption of Kubernetes continues to expand across industries, many organizations struggle with ensuring that security keeps pace. Headlines continue to show the real-world consequences of insufficient (or non-existent) container security. Zach and Susan enable us to reach more enterprises and partners, helping them achieve – and deliver – automated security and compliance from CI/CD pipeline to production.”

Zach Hill brings more than 20 years of enterprise sales experience to his role as VP of Sales at NeuVector. Much of Hill’s career has been in sales leadership roles at security technology companies, including digital security training firm MediaPRO (recently acquired by KnowBe4) and cyber threat intelligence and investigation platform provider DomainTools.

“Continuous security automation is an absolute necessity for organizations modernizing their architecture through containerization,” said Hill. “NeuVector ensures that customers can seamlessly introduce robust security across their full application lifecycles without skipping a beat with developer and DevOps team productivity. I’m excited to join NeuVector and bring this comprehensive solution to organizations around the globe.”

Susan Don joins NeuVector from Mocana Corporation, where she led global partner development for the IoT security company. Don also brings a wealth of security industry leadership experience to NeuVector; she has led business development and partnership growth at Cisco Systems, WhiteHat Security, and Akamai Technologies, among others. Don holds CISSP certification from the International Information System Security Certification Consortium.

“Solution provider and reseller partners have been a significant driver behind NeuVector’s growth,” said Don. “Our comprehensive and intuitive Kubernetes-native solution aligns well with what our partners need to deliver to their customers, and I look forward to strengthening those relationships and establishing new global partnerships.”

About NeuVector

NeuVector, the leader in full lifecycle container security, empowers global organizations to fully secure their container infrastructures without compromising business velocity. For security, DevOps, and infrastructure teams, the NeuVector continuous container security and compliance platform simplifies data protection from pipeline to production, enforces compliance, and provides unparalleled visibility and automated controls to combat known and unknown threats. To learn more about NeuVector, visit NeuVector.com.

Photos accompanying this announcement are available at:

https://www.globenewswire.com/NewsRoom/AttachmentNg/ea3c28ee-28ce-4c05-af33-0160751765ef

https://www.globenewswire.com/NewsRoom/AttachmentNg/52ea4e27-4e1b-4e21-9f64-4efc3995e9f9

DRAPER, Utah, May 11, 2021 (GLOBE NEWSWIRE) — HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the largest independent HSA custodian, today announced plans to release its first quarter of fiscal 2022 financial results following the close of regular stock market trading hours on Monday, June 7, 2021. Following the news release, HealthEquity management plans to host a conference call for investors on Monday, June 7, 2021, at 4:30 p.m. ET during which management will review highlights from the Company’s first quarter results.

The Company also announced that it plans to participate at the following upcoming investor conferences:

About HealthEquity

HealthEquity and its subsidiaries administers Health Savings Accounts (HSAs) and other consumer-directed benefits for our more than 12 million accounts in partnership with employers, benefits advisors, and health and retirement plan providers who share our mission to connect health and wealth and value our culture of remarkable “Purple” service. For more information, visit www.healthequity.com.

Forward-looking statements

This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding our industry, business strategy, plans, goals and expectations concerning our markets and market position, product expansion, future operations, expenses and other results of operations, revenue, margins, profitability, future efficiencies, tax rates, capital expenditures, liquidity and capital resources and other financial and operating information. When used in this discussion, the words “may,” “believes,” “intends,” “seeks,” “anticipates,” “plans,” “estimates,” “expects,” “should,” “assumes,” “continues,” “could,” “will,” “future” and the negative of these or similar terms and phrases are intended to identify forward-looking statements in this press release.

Forward-looking statements reflect our current expectations regarding future events, results or outcomes. These expectations may or may not be realized. Although we believe the expectations reflected in the forward-looking statements are reasonable, we can give you no assurance these expectations will prove to be correct. Some of these expectations may be based upon assumptions, data or judgments that prove to be incorrect. Actual events, results and outcomes may differ materially from our expectations due to a variety of known and unknown risks, uncertainties and other factors. Although it is not possible to identify all of these risks and factors, they include, among others, risks related to the following:

• the impact of the COVID-19 pandemic on the Company, its operations and its financial results;
• our ability to realize the anticipated financial and other benefits from combining the operations of WageWorks with our business in an efficient and effective manner;
• our ability to compete effectively in a rapidly evolving healthcare and benefits administration industry;
• our dependence on the continued availability and benefits of tax-advantaged health savings accounts and other consumer-directed benefits;
• our ability to successfully identify, acquire and integrate additional portfolio purchases or acquisition targets;
• the significant competition we face and may face in the future, including from those with greater resources than us;
• our reliance on the availability and performance of our technology and communications systems;
• recent and potential future cybersecurity breaches of our technology and communications systems and other data interruptions, including resulting costs and liabilities, reputational damage and loss of business;
• the current uncertain healthcare environment, including changes in healthcare programs and expenditures and related regulations;
• our ability to comply with current and future privacy, healthcare, tax, investment advisor and other laws applicable to our business;
• our reliance on partners and third-party vendors for distribution and important services;
• our ability to develop and implement updated features for our technology and communications systems and successfully manage our growth;
• our ability to protect our brand and other intellectual property rights; and
• our reliance on our management team and key team members.

For a detailed discussion of these and other risk factors, please refer to the risks detailed in our filings with the Securities and Exchange Commission, including, without limitation, our most recent Annual Report on Form 10-K and subsequent periodic and current reports. Past performance is not necessarily indicative of future results. We undertake no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.

Investor Relations Contact:

Richard Putnam
801-727-1209
[email protected]

LONDON, May 11, 2021 (GLOBE NEWSWIRE) — Ferroglobe PLC (NASDAQ:GSM) announced today that it will issue first quarter financial results after the close of the market on Monday, May 17, 2021 and will host the quarterly earnings call on Tuesday, May 18, 2021.  

Ferroglobe invites all interested persons to participate on its conference call at 9:00 AM, U.S. Eastern Daylight Time. Please dial in at least five minutes prior to the call to register. The call may also be accessed via an audio webcast. 

Date: May 18, 2021
Time: 9:00 AM EDT

Listen via Internet: https://edge.media-server.com/mmc/p/v4m27q2m

United States:   +1 877-293-5491 (conference ID: 6081005)
International:    +1 914-495-8526 (conference ID: 6081005)

About Ferroglobe

Ferroglobe is one of the world’s leading suppliers of silicon metal, silicon- and manganese-based specialty alloys, and other ferroalloys serving a customer base across the globe in dynamic and fast-growing end markets, such as solar, automotive, consumer products, construction and energy. The Company is based in London. For more information, visit http://investor.ferroglobe.com.

INVESTOR CONTACT:

Gaurav Mehta
Executive Vice President – Investor Relations
[email protected]

DELAND, Fla., May 11, 2021 (GLOBE NEWSWIRE) — Kingspan Insulated Panels North America announces new sustainability initiatives as part of the company’s global Planet Passionate program, an ambitious, decade-long commitment to cutting carbon emissions between 2020 and 2030. Through upcycling, renewable energy and a PV solar roof, a large investment in Kingspan’s plant in Modesto, California, puts Kingspan a step closer to meeting its global target with a focus on three areas:

• Energy: powering 60% of all Kingspan operations directly from renewable energy with a minimum of 20% of this energy generated on manufacturing sites
• Carbon: achieving net zero carbon manufacturing and a 50% reduction in product CO₂ intensity from primary supply partners
• Circularity: upcycling of 1 billion PET bottles per annum into insulation products plus zero company waste to landfill across all sites

The Modesto plant is using upcycled PET plastic water bottles as a key raw material input for manufacturing Kingspan’s QuadCore® insulation, as part of the global effort to meet Planet Passionate goals of upcycling a billion water bottles a year worldwide. This is a critical step toward cleaning up the world’s beaches and oceans, while providing between 9% and 12% recycled content to Kingspan’s insulation foam, depending on panel thickness.

According to the United Nations, the world produces 300 million tons of plastic waste each year, which is equivalent to the weight of the entire human population. Even more alarming is that 8% ends up in the world’s oceans. The UN estimates that by 2050, if nothing changes, the oceans could contain more plastic than fish.

Kingspan is also reducing its own carbon footprint by installing a PV solar panel roof at its Modesto plant to generate roughly 1.4 MW of on-site electricity. When finalized this summer, the Modesto plant will be on the road to meeting Kingspan’s global Planet Passionate goal of 60% direct renewable energy, while contributing to 20% on-site renewable generation. As of 2018, electricity production accounted for more than 26% of greenhouse gas emissions in the United States, according to the U.S. Energy Information Administration. The reliance on clean energy cuts both carbon emissions and pollution.

“We need to address every aspect of sustainability when it comes to the built environment. With each plant, we are finding new ways to meet and even exceed our goals in order to fulfill our commitment to tackling climate change,” said Brent Trenga, Kingspan’s Director of Sustainability. “It is critical to our planet that we assess carbon emissions in every step of the manufacturing process. We must examine every aspect from the energy sources to the materials used.”

In addition to being more energy efficient, the plant can manufacture insulated panels at almost double the speed of its predecessor and has a state-of-the-art autonomous online conditional monitoring system, making it Kingspan’s most advanced insulated panel manufacturing plant globally.

The 138,500 sq. ft. plant employs a staff of 85 and is the City of Modesto’s third largest employer. Total investment for the plant is around $23 million and it is one of Kingspan’s five plants in North America.

Kingspan has been operating in Modesto, California, since 2008.

To learn more about Kingspan, visit www.kingspanpanels.us.

About Kingspan Insulated Panels – North America

Kingspan Insulated Panels – North America is a business unit of Kingspan, a global company operating in more than 60 countries, with over 140 manufacturing facilities. Kingspan Insulated Panels – North America manufactures and markets three groups of products at its U.S. and Canadian facilities: insulated metal wall and roof panel systems for commercial/industrial construction; insulated architectural panel and façade systems for design-driven projects; and controlled environment panels and doors for cold-storage and climate-controlled warehousing. In addition to its commitment to quality and innovation, the company is on the leading edge of the sustainability movement, offering best-of-class products produced in state-of-the-art, eco-friendly facilities. To learn more visit www.kingspanpanels.us.

Media Contact:

Alyssa Cohen
Uproar PR for Kingspan Insulated Panels North America
321-236-0102 x233
[email protected]

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES

OR FOR DISSEMINATION IN THE UNITED STATES

VANCOUVER, British Columbia, May 11, 2021 (GLOBE NEWSWIRE) — 1284696 BC Ltd (the “Company” or “BCCO”), a private BC company, is pleased to announce further to its news release dated April 8, 2021, it has entered into an amalgamation agreement dated April 28, 2021 (the “Definitive Agreement”) with Spirit Blockchain Capital Inc. (“Spirit”). The Definitive Agreement is further to the Letter of Intent dated April 1, 2021. Spirit is a private company incorporated under the laws of British Columbia and has a wholly owned subsidiary, Spirit Blockchain AG, a Swiss Company.

Upon the acquisition of all the issued and outstanding shares of Spirit (the “Proposed Transaction”), BCCO intends to file a non-offering prospectus (the “Prospectus”) with the applicable securities commissions and apply for a listing (the “Listing”) on the Canadian Securities Exchange (the “Exchange”). Upon completion of the Proposed Transaction, the Company is expected to change its name to “Spirit Blockchain Capital Inc.” (the “Resulting Issuer”). It is a condition of the Proposed Transaction that the Resulting Issuer apply for Listing, however, there can be no assurance that the Exchange will approve the Listing. The Proposed Transaction is an arm’s length transaction.

About Spirit Blockchain Capital Inc.

Spirit is a Canadian Swiss group operating specifically in the Blockchain and Digital Asset sectors with the primary goal of creating value in a rapidly growing environment through recurring cash flows and capital appreciation.

Spirit provides investors with direct exposure to the sector, without the technical complexity or constraints of purchasing the underlying crypto assets. Spirit’s strategy is based upon management’s conviction that the Blockchain and Digital Asset ecosystem will register significant growth and outperform traditional asset classes over the medium to long-term.

The Company’s strategy focuses on three complementary economic units:

• Royalties & Streams by providing capital to blockchain ecosystem participants, where repayment of the notional and interest takes place in the form of crypto assets.
• Advisory & Research Services for Institutional and private Investors to a global blockchain and digital assets investment product.
• Treasury management through investment in major crypto assets with cold storage in Switzerland.

Summary of the Proposed Transaction

Pursuant to the terms of the Definitive Agreement, the Proposed Transaction will proceed by way of an amalgamation between a wholly-owned subsidiary of the Company and Spirit. An aggregate of 13,800,000 common shares of BCCO are currently issued and outstanding, prior to completing the Proposed Transaction. It is expected that 46,000,000 common shares of BCCO will be issued to the shareholders of Spirit on a pro rata basis. 

The completion of the Proposed Transaction is subject to the satisfaction of various conditions that are standard for a transaction of this nature, including but not limited to (i) the completion of the Private Placement (as defined below); (ii) if applicable, the approval of the Proposed Transaction by the shareholders of each of BCCO and Spirit, and (iii) the completion of satisfactory due diligence by each of the parties. There can be no assurance that the Proposed Transaction will be completed on the terms proposed above or at all.

Each of BCCO and Spirit will bear their own costs in respect of the Proposed Transaction.

Proposed Financing by Spirit

Prior to the completion of the Proposed Transaction, Spirit will complete a non-brokered private placement of up to 40,000,000 common shares in the capital of Spirit (“Spirit Shares”) at a price of $0.125 per share for gross proceeds of up to $5,000,000 (the “Private Placement”). The proceeds raised in connection with the Private Placement will be used to fund the operations of Spirit (and the Resulting Issuer) and for general working capital. All securities issued pursuant to the Private Placement will be subject to an indefinite hold period under applicable securities laws until the common shares of the Resulting Issuer are approved for listing on the Exchange. Commissions may be paid on proceeds raised commensurate with industry norms.

Spirit intends to invite qualified investors who strongly resonate with Spirit’s vision for digital currency, including the mass adoption of digital assets, potential widespread application of Blockchain technology, and the unique revenue driven business model of Spirit.

Proposed Concurrent Financing by BCCO

It is currently expected that prior to or concurrent with completion of the filing of the Prospectus, BCCO will complete at least one additional financing at a price to be determined (currently expected to be in the range of S0.30 to $0.40 per share) and subject to market conditions, for gross proceeds of not less than $1,000,000 (the “Concurrent Offering”). The proceeds raised in connection with the Concurrent Offering will be used to fund the costs associated with completing the Proposed Transaction, and for general working capital of the Resulting Issuer. All securities issued pursuant to the Concurrent Offering will be subject to an indefinite hold period under applicable securities laws. Commissions may be paid on proceeds raised commensurate with industry norms.

ON BEHALF OF THE BOARD OF DIRECTORS:

Karan Thakur
President and Director

For further information, please contact:
Erich Perroulaz, Chairman & CEO
[email protected]

No securities regulatory authority has either approved or disapproved of the contents of this news release.

This press release is not an offer of the securities for sale in the United States.


The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities laws. Accordingly, the securities may not be offered or sold within the United States or to U.S. persons (as defined in Regulation S under the U.S. Securities Act) unless registered under the U.S. Securities Act and applicable state securities laws, or pursuant to exemptions from the registration requirements of the U.S. Securities Act and applicable state securities laws. This news release does not constitute an offer to sell or a solicitation of an offer to buy any securities of BCCO, Spirit or the Resulting Issuer in any jurisdiction in which such offer, solicitation or sale would be unlawful.

Disclaimer for Forward-Looking Information

This press release contains forward-looking statements and information that are based on the beliefs of management and reflect BCCO’s current expectations. When used in this press release, the words “estimate”, “project”, “belief”, “anticipate”, “intend”, “expect”, “plan”, “predict”, “may” or “should” and the negative of these words or such variations thereon or comparable terminology are intended to identify forward-looking statements and information. The forward-looking statements and information in this press release include information relating to the business plans of BCCO, Spirit, and the Resulting Issuer, the Private Placement, the Concurrent Offering, the Proposed Transaction (including Exchange approval and Listing). Such statements and information reflect the current view of BCCO. Risks and uncertainties that may cause actual results to differ materially from those contemplated in those forward-looking statements and information.

By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.

THE FORWARD-LOOKING INFORMATION CONTAINED IN THIS PRESS RELEASE REPRESENTS THE EXPECTATIONS OF BCCO AS OF THE DATE OF THIS PRESS RELEASE AND, ACCORDINGLY, IS SUBJECT TO CHANGE AFTER SUCH DATE. READERS SHOULD NOT PLACE UNDUE IMPORTANCE ON FORWARD-LOOKING INFORMATION AND SHOULD NOT RELY UPON THIS INFORMATION AS OF ANY OTHER DATE. WHILE BCCO MAY ELECT TO, IT DOES NOT UNDERTAKE TO UPDATE THIS INFORMATION AT ANY PARTICULAR TIME EXCEPT AS REQUIRED IN ACCORDANCE WITH APPLICABLE LAWS.

SAN DIEGO, CA, May 11, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® Brasil had its best revenue month ever in Company history in April 2021.

“Our HempMeds Brasil operations have seen a consistent increase over the years. We aim to reach as many consumers in need as possible and last month’s achievements prove that we are continuing to expand our reach to our target audiences,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus.

“I am incredibly proud of the success our HempMeds Brasil team has been able to achieve. As we celebrate our best revenue month in company history, we are scaling our operations in the country, refreshing our consumer-facing website and increasing the size of our facilities in Brazil to meet the needs of our expanding team,” said HempMeds® CEO Raul Elizalde.

“In the coming months, to support our continued growth, we intend to partner with the largest higher education institution in Brazil to educate medical professionals on the potential benefits of cannabidiol (CBD) and are moving forward in securing partnerships with well-respected professional and Olympic athletes,” said HempMeds® Brasil Managing Director Matheus Patelli. “My team has successfully been able to show Brazilian citizens that our products are of the highest quality and trustworthy, just like the people who work at the Company.”

To learn more about HempMeds® Brasil, please visit www.hempmeds.com.br.

About HempMeds® Brasil
HempMeds® Brasil was the first company to receive approval from the National Sanitary Surveillance Agency (Anvisa) to import a product based on cannabidiol, a substance derived from hemp, a plant of the genus Cannabis. Currently, it is authorized to supply its products, which help in the control of diseases such as epilepsy, Parkinson’s, chronic pain and multiple sclerosis, under medical prescription. For these indications, the products can be subsidized by the Brazilian government. HempMeds® Brasil is working on additional approvals for other indications. www.hempmeds.com.br.

About Medical Marijuana, Inc.
We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Kannalife, Inc. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company’s flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.

Medical Marijuana, Inc.’s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.’s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

LEGAL DISCLOSURE

Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.

CONTACT:

Public Relations Contact:
Kathryn Brown
Account Supervisor
CMW Media
P. 858-264-6600
[email protected]
www.cmwmedia.com 

Investor Relations Contact:
P. (858) 283-4016
[email protected]